The Cancer Letter

Inside information on cancer research and drug development

Vol.
22
No.
25
June 21, 1996Jun 21, 1996
Free
DOWNLOAD THE PDF

House Subcommittee Recommends $137.7 Million Increase For NCI

In Brief: GM awards Shared By Six Scientists; Pollard Named President of Salk Institute

NCI Names Brawly Director of Office of Special Populations

Owens Becomes President, NCCR

FDA approves Irinotecan, Days After ODAC Meeting

ODAC Recommends FDA Approval For Grain Tumor Implant

Letter: Headline Criticized On Letter About Consortium

Login

Site license subscribers:
Log in with your IP | Register a sponsored account